The Translator program is funded through the Cures Acceleration Network (CAN). CAN is designed to advance the development of high-need cures and reduce significant barriers between research discovery and clinical trials. Learn more about the Biomedical Data Translator program.
-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- About NCATS
- Home
- About NCATS
- NCATS Programs & Initiatives
- Biomedical Data Translator
Biomedical Data Translator
Deconstructing the Translational Tower of BabelFind out how NCATS’ Biomedical Data Translator program aims to help bridge informatics gaps in an editorial by NCATS leadership in Clinical and Translational Science.
About Biomedical Data TranslatorLearn more about the Biomedical Data Translator program and its objectives.
Funding InformationFind out how to apply for Biomedical Data Translator funding.
About Biomedical Data Translator
Learn more about the Biomedical Data Translator program and its objectives.
Find out how to apply for Biomedical Data Translator funding.
Work With Us
Learn more about how you can access funding and collaborate with NCATS through the Biomedical Data Translator program.
Learn more about NCATS’ Achievements in Advancing Translational Sciences.
Building a Data Translator
NCATS launched the Biomedical Data Translator program as a multiyear, iterative effort toward the eventual development of a comprehensive and relational “data translator” that integrates multiple types of existing data sources. These sources may include objective signs and symptoms of disease, drug effects, and intervening types of biological data relevant to understanding pathophysiology. Now in the development phase of the program, the fully realized Translator will be designed to enhance human reasoning and enable a significant shift from the current symptom-based diagnosis of disease classification to one that is based on a set of molecular and cellular abnormalities that can be targeted by various preventive and therapeutic interventions.
NCATS Programs & Initiatives
- Funding & Notices
-